”Our journey towards long-term profitability improvement continues and we deliver yet another quarter of growth and increased profitability. The positive development in rental and service continued globally and we navigate the market in a good way, despite short-term challenges. There is a major need for investments in healthcare and overall we see healthy growth opportunities moving forward,” says Joacim Lindoff, President and CEO of Arjo.

April-June 2024 in brief

• Net sales increased to SEK 2,810 M (2,686). Net sales grew organically by 3.7%.
• Adjusted EBITDA increased to SEK 496 M (471).
• Adjusted operating profit increased 10.6% to SEK 232 M (210).
• Profit after financial items increased to SEK 164 M (139).
• Earnings per share rose to SEK 0.44 (0.38).
• Cash flow from operations amounted to SEK 344 M (512), corresponding to a cash conversion of 69.7% (113.8).

Telephone conference

Fund managers, analysts and media are invited to participate in a conference call and presentation of the report on July 12 at 08:00 CEST via the following link:
https://ir.financialhearings.com/arjo-q2-report-2024

Those who wish to ask questions verbally during the teleconference will need to register via the link below. A phone number and a conference ID will be provided after registration in order to access the conference. Link to registration: https://conference.financialhearings.com/teleconference/?id=50049841

Alternatively, use the following link to download the presentation:
https://www.arjo.com/int/about-us/investors/reports--presentations/2024/

A recorded version of the conference is accessible for three years via the following link: https://ir.financialhearings.com/arjo-q2-report-2024
 

For more information, please contact:

Maria Nilsson, EVP Communications & Public Relations

Tel: +46 734 244 515

Email: maria.nilsson@arjo.com  

Sara Ehinger, VP Investor Relations & Corporate Communications

Tel: +46 723 597 794

Email: sara.ehinger@arjo.com

This information is information that Arjo AB is obliged to make public pursuant to the EU Market Abuse Regulation and the Securities Markets Act. The information was submitted for publication, through the agency of the contact person set out above, at 07:00 CEST on July 12, 2024.

About Arjo

At Arjo, we believe that empowering movement within healthcare environments is essential to quality care. Our products and solutions are designed to promote a safe and dignified experience through patient handling, medical beds, personal hygiene, disinfection, diagnostics, and the prevention of pressure injuries and venous thromboembolism. With more than 6,500 people worldwide and over 65 years caring for patients and healthcare professionals, we are committed to driving healthier outcomes for people facing mobility challenges. www.arjo.com